Harnessing the Power of the Microbiome to Revolutionize Treatment of Disease
Rebiotix Inc. is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome.
It is increasingly recognized that restoration of a healthy gut microbiota is necessary for the effective treatment of a large number of challenging diseases.
The Leader in Developing Microbiota-Based Therapies through the MRT™ Drug Platform
The MRT platform is our science for delivering live, human-derived microbes into a sick patient’s intestinal tract to treat disease.
We have the most advanced human clinical program evaluating a microbiota-based drug conducted in coordination with a regulatory authority. Our research encompasses studies with acute and chronic disease states, from both Rebiotix- and physician-sponsored studies. Check out our clinical program for more information.